BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  GlaxoSmithKline Poaches New CSO From Google’s Calico

  Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Bay Area’s Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi

  Sanofi will write a check for $40 million upfront.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

  ImmunoMolecular Therapeputics officially launched yesterday.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  How Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav

  The FDA approved Dynavax’s Heplisav-B, it’s first new hepatitis B vaccine in the U.S. in more than 25 years.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Siemens to Replace Healthineers CFO in Preparation for Listing

  The public listing is expected to value the business at around $46 billion.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  GlaxoSmithKline’s Pain in China is AstraZeneca’s Gain

  China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.

  November 9, 2017

   · 

  1 min read
• 

  Business

  Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected

  The company will explore opportunity to close facilities during second half of 2019.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression

  The positive results support the company’s planned regulatory submissions.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  AiCuris to Pocket $122M as Merck Wins FDA Approval for New CMV Infection Drug

  CMV is a common and potentially serious viral infection in allogeneic HSCT recipients.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• Business

  Leti Joins DARPA-Funded Consortium of Seeing and Hearing Foundation to Develop Implantable Device for Restoring Vision

  Leti announced today that a team of its researchers is participating in a U.S.-funded project to develop a safe, implantable neural interface system to restore vision by stimulating the visual cortex.

  November 9, 2017

   · 

  4 min read